OneSource Specialty (ONESOURCE) | Stock Overview & Key Data
OneSource Specialty Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹2,248.00 on June 18, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OneSource Specialty
ONESOURCE
|
202.76B Large-cap | -6.58% | -11.52% | 8.72% | 0.44% | -9.19% | -20.38% | -5.70% | -5.70% | -5.70% | -5.70% | -5.70% |
|
Biocon
BIOCON
|
566.52B Large-cap | 1.66% | -3.27% | 10.34% | 6.50% | 7.30% | 17.90% | 71.09% | 5.03% | 250.57% | 603.49% | 1,357.39% |
|
Concord Biotech
CONCORDBIO
|
106.31B Mid-cap | 15.33% | 21.57% | 19.18% | 1.44% | 3.29% | -35.83% | 43.59% | 43.59% | 43.59% | 43.59% | 43.59% |
|
Blue Jet Healthcare
BLUEJET
|
69.97B Mid-cap | 11.86% | 17.17% | 41.50% | -8.00% | -4.67% | -46.26% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% |
|
Supriya Lifescience
SUPRIYA
|
51.74B Mid-cap | 3.93% | 38.73% | 66.47% | 32.20% | 28.93% | 41.71% | 283.42% | 102.02% | 102.02% | 102.02% | 102.02% |
|
Zota Health Care
ZOTA
|
39.41B Small-cap | 3.68% | 3.22% | 14.06% | -26.10% | -17.99% | 27.17% | 243.00% | 632.12% | 1,248.00% | 1,248.00% | 1,248.00% |
Ownership & Short Interest
Calculate Your OneSource Specialty Investment Returns
Long-Term Investment Performance Analysis
OneSource Specialty stock price in Jan 2025 was ₹1,710.00, A ₹1,000.00 lump sum investment in OneSource Specialty made 1 years ago would be worth approximately ₹949.36 today, representing a negative return of -5.06%. This translates to an annualized return (CAGR) of -3.65%.
1 Year 4 Months Investment Scenario (Jan 2025 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ONESOURCE's 52-week high and low?
- In the last 52 weeks, OneSource Specialty reached a high of ₹2,248.00 (on June 18, 2025) and a low of ₹1,057.00 (on January 30, 2026).
- What is the market cap and P/E ratio for ONESOURCE?
- Curious about OneSource Specialty's size and valuation? Its market capitalization stands at 202.76B. When it comes to valuation, the P/E ratio (trailing twelve months) is 936.63, and the forward P/E (looking ahead) is 42.24.
- Does ONESOURCE pay dividends? If so, what's the yield?
- As for dividends, OneSource Specialty isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are OneSource Specialty's main competitors or similar companies to consider before investing?
When looking at OneSource Specialty, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON566.52B Healthcare Biotechnology 17.90% 71.09% Concord Biotech
CONCORDBIO106.31B Healthcare Biotechnology -35.83% 43.59% Blue Jet Healthcare
BLUEJET69.97B Healthcare Biotechnology -46.26% 31.46% Supriya Lifescience
SUPRIYA51.74B Healthcare Biotechnology 41.71% 283.42% Zota Health Care
ZOTA39.41B Healthcare Biotechnology 27.17% 243.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for OneSource Specialty Pharma Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of OneSource Specialty's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.31%, the Debt to Equity ratio from the most recent quarter is 21.93, and its Gross Profit Margin stands at 67.50%.
- What is the recent revenue and earnings growth for ONESOURCE?
- Looking at OneSource Specialty's growth, its revenue over the trailing twelve months (TTM) was INR14B. Compared to the same quarter last year (YoY), quarterly revenue grew by -26.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of ONESOURCE stock is held by insiders and institutions?
- Wondering who owns OneSource Specialty stock? Company insiders (like executives and directors) hold about 38.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 26.67%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.